DCTH
Delcath Systems Inc
NASDAQ: DCTH · HEALTHCARE · MEDICAL DEVICES
$13.01
-3.77% today
Updated 2026-07-10
Market cap
$446.71M
P/E ratio
1,294.00
P/S ratio
4.94x
EPS (TTM)
$0.01
Dividend yield
—
52W range
$8 – $13
Volume
0.5M
Delcath Systems Inc (DCTH) Insider transactions
Net insider activity
Net buying (13,134,694 shares)
Buy transactions
95
Sell transactions
5
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-13 | SYLVESTER, JOHN RICHARD | Director | Buy | 22,500 | — | — |
| 2026-05-13 | SALAMON, STEVEN A J | Director | Buy | 22,500 | — | — |
| 2026-05-13 | MARTELL, BRIDGET A | Director | Buy | 22,500 | — | — |
| 2026-05-13 | CZEREPAK, ELIZABETH | Director | Buy | 22,500 | — | — |
| 2026-05-13 | AHARON, GIL | Director | Buy | 22,500 | — | — |
| 2026-03-06 | PENNELL, SANDRA | Chief Financial Officer | Buy | 5,533 | $9.04 | $50018.32 |
| 2026-03-02 | MICHEL, GERARD J | Director, CHIEF EXECUTIVE OFFICER | Buy | 11,200 | $8.96 | $100309.44 |
| 2026-02-17 | VUKOVIC, VOJO | CHIEF MEDICAL OFFICER | Buy | 56,500 | — | — |
| 2026-02-17 | VUKOVIC, VOJO | CHIEF MEDICAL OFFICER | Buy | 28,250 | — | — |
| 2026-02-17 | ROOK, MARTHA S. | CHIEF OPERATING OFFICER | Buy | 56,500 | — | — |
| 2026-02-17 | ROOK, MARTHA S. | CHIEF OPERATING OFFICER | Buy | 28,250 | — | — |
| 2026-02-17 | PENNELL, SANDRA | Chief Financial Officer | Buy | 56,500 | — | — |
| 2026-02-17 | PENNELL, SANDRA | Chief Financial Officer | Buy | 28,250 | — | — |
| 2026-02-17 | MUIR, KEVIN | GM INTERVENTIONAL ONCOLOGY | Buy | 56,500 | — | — |
| 2026-02-17 | MUIR, KEVIN | GM INTERVENTIONAL ONCOLOGY | Buy | 28,250 | — | — |
| 2026-02-17 | MICHEL, GERARD J | Director, CHIEF EXECUTIVE OFFICER | Buy | 195,000 | — | — |
| 2026-02-17 | MICHEL, GERARD J | Director, CHIEF EXECUTIVE OFFICER | Buy | 97,500 | — | — |
| 2026-02-17 | HOFFMAN, DAVID L. | GEN'L COUNSEL, CCO & SECY | Buy | 56,500 | — | — |
| 2026-02-17 | HOFFMAN, DAVID L. | GEN'L COUNSEL, CCO & SECY | Buy | 28,250 | — | — |
| 2025-11-21 | SYLVESTER, JOHN RICHARD | Director | Buy | 4,386 | $8.89 | $38991.54 |
| 2025-11-11 | MICHEL, GERARD J | Director, CHIEF EXECUTIVE OFFICER | Buy | 11,500 | $8.53 | $98049.00 |
| 2025-06-12 | VUKOVIC, VOJO | CHIEF MEDICAL OFFICER | Sale | 42,000 | — | — |
| 2025-06-12 | VUKOVIC, VOJO | CHIEF MEDICAL OFFICER | Buy | 42,000 | $4.78 | $200760.00 |
| 2025-05-15 | SYLVESTER, JOHN RICHARD | Director | Buy | 22,500 | — | — |
| 2025-05-15 | SALAMON, STEVEN A J | Director | Buy | 22,500 | — | — |
| 2025-05-15 | MARTELL, BRIDGET A | Director | Buy | 22,500 | — | — |
| 2025-05-15 | CZEREPAK, ELIZABETH | Director | Buy | 22,500 | — | — |
| 2025-05-15 | AHARON, GIL | Director | Buy | 22,500 | — | — |
| 2025-05-05 | SALAMON, STEVEN A J | Director | Buy | 400,000 | $10.00 | $4.00M |
| 2025-05-05 | ROSALIND, ADVISORS, INC. | Director | Buy | 400,000 | $10.00 | $4.00M |
| 2025-05-05 | AHARON, GIL | Director | Buy | 400,000 | $10.00 | $4.00M |
| 2025-02-07 | VUKOVIC, VOJO | CHIEF MEDICAL OFFICER | Buy | 113,000 | — | — |
| 2025-02-07 | ROOK, MARTHA S. | CHIEF OPERATING OFFICER | Buy | 113,000 | — | — |
| 2025-02-07 | PENNELL, SANDRA | Chief Financial Officer | Buy | 113,000 | — | — |
| 2025-02-07 | MUIR, KEVIN | GM INTERVENTIONAL ONCOLOGY | Buy | 113,000 | — | — |
| 2025-02-07 | MICHEL, GERARD J | Director, CHIEF EXECUTIVE OFFICER | Buy | 390,000 | — | — |
| 2025-02-07 | HOFFMAN, DAVID L. | GEN'L COUNSEL, CCO & SECY | Buy | 113,000 | — | — |
| 2024-12-24 | SALAMON, STEVEN A J | Director | Buy | 603,954 | $9.99 | $6.03M |
| 2024-12-24 | SALAMON, STEVEN A J | Director | Buy | 250,000 | $10.00 | $2.50M |
| 2024-12-24 | ROSALIND, ADVISORS, INC. | Director | Buy | 603,954 | $9.99 | $6.03M |
| 2024-12-24 | ROSALIND, ADVISORS, INC. | Director | Buy | 250,000 | $10.00 | $2.50M |
| 2024-12-24 | AHARON, GIL | Director | Buy | 603,954 | $9.99 | $6.03M |
| 2024-12-24 | AHARON, GIL | Director | Buy | 250,000 | $10.00 | $2.50M |
| 2024-10-30 | SALAMON, STEVEN A J | Director | Buy | 500 | $1,000.00 | $500000.00 |
| 2024-10-30 | SALAMON, STEVEN A J | Director | Buy | — | — | — |
| 2024-10-30 | ROSALIND, ADVISORS, INC. | Director | Buy | 500 | $1,000.00 | $500000.00 |
| 2024-10-30 | ROSALIND, ADVISORS, INC. | Director | Buy | — | — | — |
| 2024-10-30 | AHARON, GIL | Director | Buy | 500 | $1,000.00 | $500000.00 |
| 2024-10-30 | AHARON, GIL | Director | Buy | — | — | — |
| 2024-10-22 | MICHEL, GERARD J | Director, CHIEF EXECUTIVE OFFICER | Sale | 16,666 | $0.13 | $2083.25 |
| 2024-10-22 | MICHEL, GERARD J | Director, CHIEF EXECUTIVE OFFICER | Buy | 16,666 | $6.00 | $99996.00 |
| 2024-05-23 | SYLVESTER, JOHN RICHARD | Director | Buy | 22,500 | — | — |
| 2024-05-23 | STOLL, ROGER G PHD | Director | Sale | 40,000 | — | — |
| 2024-05-23 | STOLL, ROGER G PHD | Director | Sale | 19,682 | — | — |
| 2024-05-23 | STOLL, ROGER G PHD | Director | Buy | 9,000 | — | — |
| 2024-05-23 | STOLL, ROGER G PHD | Director | Buy | 142 | — | — |
| 2024-05-23 | SALAMON, STEVEN A J | Director | Buy | 22,500 | — | — |
| 2024-05-23 | MARTELL, BRIDGET A | Director | Buy | 22,500 | — | — |
| 2024-05-23 | CZEREPAK, ELIZABETH | Director | Buy | 22,500 | — | — |
| 2024-05-23 | AHARON, GIL | Director | Buy | 22,500 | — | — |
| 2024-04-18 | SALAMON, STEVEN A J | Director | Buy | 991,615 | — | — |
| 2024-04-18 | SALAMON, STEVEN A J | Director | Buy | 619,946 | $0.01 | $6199.46 |
| 2024-04-18 | ROSALIND, ADVISORS, INC. | Director | Buy | 991,615 | — | — |
| 2024-04-18 | ROSALIND, ADVISORS, INC. | Director | Buy | 619,946 | $0.01 | $6199.46 |
| 2024-04-18 | AHARON, GIL | Director | Buy | 991,615 | — | — |
| 2024-04-18 | AHARON, GIL | Director | Buy | 619,946 | $0.01 | $6199.46 |
| 2024-03-19 | VUKOVIC, VOJO | CHIEF MEDICAL OFFICER | Buy | 26,882 | $3.72 | $100001.04 |
| 2024-03-19 | SALAMON, STEVEN A J | Director | Buy | 26,882 | $3.72 | $100001.04 |
| 2024-03-19 | ROSALIND, ADVISORS, INC. | Director | Buy | 619,946 | $3.71 | $2.30M |
| 2024-03-19 | PENNELL, SANDRA | SVP OF FINANCE, PFO AND PAO | Buy | 26,881 | $3.72 | $99997.32 |
| 2024-03-19 | MUIR, KEVIN | GM INTERVENTIONAL ONCOLOGY | Buy | 13,441 | $3.72 | $50000.52 |
| 2024-03-19 | MICHEL, GERARD J | Director, CHIEF EXECUTIVE OFFICER | Buy | 40,323 | $3.72 | $150001.56 |
| 2024-03-19 | HOFFMAN, DAVID L. | GEN'L COUNSEL, CCO & SECY | Buy | 20,161 | $3.72 | $74998.92 |
| 2024-03-19 | AHARON, GIL | Director | Buy | 26,882 | $3.72 | $100001.04 |
| 2024-03-18 | ROOK, MARTHA S. | CHIEF OPERATING OFFICER | Buy | 125,000 | — | — |
| 2024-02-12 | VUKOVIC, VOJO | CHIEF MEDICAL OFFICER | Buy | 100,500 | — | — |
| 2024-02-12 | PENNELL, SANDRA | SVP OF FINANCE, PFO AND PAO | Buy | 100,500 | — | — |
| 2024-02-12 | MUIR, KEVIN | VP COMMERCIAL OPERATIONS | Buy | 100,500 | — | — |
| 2024-02-12 | MICHEL, GERARD J | Director, CHIEF EXECUTIVE OFFICER | Buy | 301,500 | — | — |
| 2024-02-12 | HOFFMAN, DAVID L. | GEN'L COUNSEL, CCO & SECY | Buy | 100,500 | — | — |
| 2023-12-12 | VUKOVIC, VOJO | Chief Medical Officer | Buy | 40,000 | $3.00 | $120000.00 |
| 2023-12-08 | MICHEL, GERARD J | Director, Chief Executive Officer | Buy | 34,000 | $2.94 | $99960.00 |
| 2023-11-17 | ROSALIND, ADVISORS, INC. | Director | Buy | 100,000 | $2.40 | $240410.00 |
| 2023-11-17 | PENNELL, SANDRA | SVP of Finance, PFO and PAO | Buy | 30,000 | $2.43 | $72900.00 |
| 2023-11-16 | VUKOVIC, VOJO | Chief Medical Officer | Buy | 60,000 | $2.48 | $148800.00 |
| 2023-11-16 | HOFFMAN, DAVID L. | See Remarks | Buy | 40,000 | $2.48 | $99200.00 |
| 2023-10-13 | PURPURA, JOHN | Chief Operating Officer | Buy | 14,505 | $3.44 | $49897.20 |
| 2023-08-21 | SYLVESTER, JOHN RICHARD | Director | Buy | 10,550 | $4.80 | $50640.00 |
| 2023-08-18 | MICHEL, GERARD J | Director, Chief Executive Officer | Sale | 31,110 | $0.13 | $3888.75 |
| 2023-08-18 | MICHEL, GERARD J | Director, Chief Executive Officer | Buy | 31,110 | $4.50 | $139995.00 |
| 2023-06-12 | SYLVESTER, JOHN RICHARD | Director | Buy | 19,682 | — | — |
| 2023-06-12 | STOLL, ROGER G PHD | Director | Buy | 19,682 | — | — |
| 2023-06-12 | SALAMON, STEVEN A J | Director | Buy | 19,682 | — | — |
| 2023-06-12 | PURPURA, JOHN | Chief Operating Officer | Buy | 59,813 | — | — |
| 2023-06-12 | PENNELL, SANDRA | See Remarks | Buy | 100,000 | — | — |
| 2023-06-12 | MUIR, KEVIN | See Remarks | Buy | 59,813 | — | — |
| 2023-06-12 | MICHEL, GERARD J | Director, Chief Executive Officer | Buy | 168,887 | — | — |
| 2023-06-12 | JOHN, JOHNNY | See Remarks | Buy | 59,813 | — | — |
| 2023-06-12 | HOFFMAN, DAVID L. | See Remarks | Buy | 59,813 | — | — |
| 2023-06-12 | CZEREPAK, ELIZABETH | Director | Buy | 19,682 | — | — |
Frequently asked questions
Are DCTH insiders buying or selling?
Over the transactions on record, DCTH insiders have been net buyers, with about $5972.00 in stock sold across 5 sales, against 38 open-market purchases.
Does insider selling at DCTH mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which DCTH insiders are selling the most?
Recent selling is concentrated in a few names. MICHEL, GERARD J accounts for the largest share on record, with about $5972.00 sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.